WE TAKE CARE OF THE HEALTH OF MILLIONS OF PEOPLE AROUND THE WORLD
GENERIC MEDICINES THAT TAKE CARE OF PEOPLE’S HEALTH
Part of the ESTEVE pharmaceutical chemical group of companies, we are focused on the development, manufacturing and global commercialization of generic medicines.
Our finished product manufacturing plant is located 20km from Barcelona (Spain), where we simultaneously carry out our own as well as third party manufacturing. Within an area of over 30,000 m2, our state-of-the-art facilities currently manufacture over 120 million units a year corresponding to more than 600 pharmaceutical references.
WE WORK WITH THE HIGHEST SAFETY AND QUALITY STANDARDS IN DRUG MANUFACTURING
AT THE CUTTING-EDGE OF INNOVATION
Preserving the commitment and innovative spirit of our foundation, our goal is to contribute to the rationalization of health resources, to provide solutions to health professionals’ needs, and to watch over the quality of life of millions of people around the world.
We are leaders in pharmaceutical innovation of generic medicines. Our Pharmaceutical Innovation and Development Area (aka “INFA”) has developed and manufactured such innovative products as:
• Second-gen Omeprazole: smaller and with many different advantages.
• Duloxetine: innovative development in pellets with own synthesis raw material, marketed in Europe and the United States.
WE INNOVATE TO RESPOND TO THE HEALTH PROFESSIONALS’ NEEDS, ALWAYS WATCHING OVER PEOPLE’S QUALIFY OF LIFE
OUR STRATEGIC OBJECTIVES
- EXCELLENCE. To comply with the highest quality standards, with the guarantee of belonging to ESTEVE.
- COMMITMENT TO R&D&I To obtain safe and effective drugs.
- SOSTENIBILITY. To ensure proper care of the environment, implementing an environmental management system (EMS).
- ACCESSIBILITY TO TREATMENTS. To offer the largest number of drug products while rationalizing health resources more efficiently.
- RESPONSE TO THE SECTOR’S DEMANDS.To support and inform health professionals to develop their activity.